Objective: This study investigated the association between small vessel disease (SVD) burden, a combination of multiple SVD markers and cognitive dysfunction after stroke. Methods: The study sample comprised 451 patients with first-ever acute ischemic stroke. Cognitive functions were assessed with the Mini-Mental State Examination (MMSE) at 3, 9, and 15 months after the index stroke. Cognitive impairment was defined as an MMSE score of 26. A total SVD score, indicating SVD burden, was constructed by summing the scores of the 4 SVD markers (white matter hyperintensities [WMHs], lacunes, cerebral microbleeds, and perivascular spaces) ascertained by magnetic resonance imaging (range: 0-4). The association between SVD burden and cognitive dysfunction was assessed with linear mixed models or generalized estimating equation models, as appropriate. Results: The majority of patients had mild-to-moderate stroke and at least one identifiable SVD marker. Cognitive impairment was found in about one-third of patients. After adjusting for confounding factors, the SVD burden was associated with MMSE scores (b ¼ À0.37, P ¼ .003) and cognitive impairment (odds ratio [OR] ¼ 1.20, 95% confidence interval [CI] ¼ 1.02-1.42). SVD burden was specifically associated with the performance of MMSE subscores including orientation to place and time, calculation, and word recall. Of the SVD markers, WMHs was the most robust predictor of decrease in MMSE scores (b ¼ À0.25, P ¼ .01) and cognitive impairment (OR ¼ 1.14, 95% CI ¼ 1.01-1.29). Conclusion: Cerebral SVD burden is associated with decreased MMSE scores, suggesting cognitive dysfunction during the first year after mild-to-moderate acute ischemic stroke.
Introduction
Cognitive impairment in stroke survivors impedes physical rehabilitation, 1 increases the risk of mortality, 1 and stroke recurrence. 2 Cerebral small vessel disease (SVD) is one of the leading causes of poststroke cognitive impairment. 3 SVD arises from diseases affecting the perforating cerebral vessels that cause brain damage in the white and deep gray matter that eventually present as white matter hyperintensities (WMHs), lacunes, cerebral microbleeds, or enlarged perivascular spaces on magnetic resonance imaging (MRI). 4 Lacunes burden, a composite of several SVD markers, is showed to be better predictor of poststroke depressive symptoms, 5 disability, 6 or recurrence of stroke. 7 However, the data concerning the relationship between SVD burden and poststroke cognitive functions are inconsistent. The accumulation of SVD markers predicted worse cognitive performance in a mixed population including patients with lacunar stroke or hypertension. 8 The subsequent longitudinal results of the study revealed that the SVD total score served as an optimal alternative to WMHs in predicting cognitive decline at 4-year follow-up. 9 A recent cross-sectional study reported that a combination of lacunes, WMHs, and perivascular spaces, modeled with a machine learning tool, was a better predictor of cognitive performance at 3 to 6 months after stroke than the stroke lesion itself or one SVD marker. 10 In contrast, the (Tel-Aviv Brain Acute Stroke Cohort) TABASCO study demonstrated that a combination of all SVD markers did not significantly predict cognitive performance at 1 year after stroke or transient ischemic attack (TIA). 11 The above studies either recruited diagnostically mixed populations, 8, 9, 11 had cross-sectional designs, 8, 10 failed to use all 4 SVD markers, 10 or lacked information on cognitive changes. 11 To extend the previous findings, the present study was set out to validate the predictive value of the SVD score in determining cognitive dysfunction measured with Mini-Mental State Examination (MMSE) over the first year after stroke in a well-characterized cohort of patients with acute ischemic stroke.
Materials and Methods

Study Population
Participants who were eligible for the study were patients with first-ever acute ischemic stroke of all etiological subtypes admitted to the Stroke Unit, Prince of Wales Hospital, Hong Kong, from February 2010 to December 2015, and who had an MRI examination within 7 days of admission. The exclusion criteria were (1) refusal to participate or loss of contact; (2) documented dementia prior to the index stroke; (3) history of neurological diseases such as brain tumor, brain trauma, or Parkinson's disease; (4) severe comorbid medical conditions such as heart or renal failure or cancer; (5) severe aphasia, auditory or visual impairments, or severe physical frailty; (6) recurrent stroke or death during 15-month follow-ups; and (7) non-Chinese ethnicity. Participants were requested to attend 3 followup appointments: T1 (3 months after stroke), T2 (9 months after stroke), and T3 (15 months after stroke). Only patients who participated in the assessments at both T1 and T3 were included in the final cohort (n ¼ 451).
Ethical Consideration and Statement
The study protocol was approved by the Joint Chinese University of Hong Kong-New Territories East Cluster Clinical Research Ethics Committee. Valid written consent was obtained from all participants.
Data Collection
Within 7 days of the index admission (T0), demographic data (age, sex, and years of education) and vascular risk factors (smoking, history of and current hypertension, hyperlipidemia, diabetes mellitus, ischemic heart disease, and atrial fibrillation) were collected. Stroke severity was assessed with the National Institutes of Health Stroke Scale (NIHSS). 12 
Neuropsychiatric Assessments
At each visit (T1, T2, and T3), overall cognitive function was assessed with the Hong Kong version of the MMSE. 13 Cognitive impairment was defined as an MMSE score of 26. This cutoff has been validated as having good sensitivity (0.71) and specificity (0.85) in diagnosing poststroke cognitive impairment. 14 In according with previous research, 15 we summed up specific scores of MMSE as follows: (1) orientation to place and time (summed scores of the first and second items, range 0-10), (2) word repetition (score of the third item, range 0-3), (3) calculation (score of the fourth item, range 0-5), (4) word recall (scores of the fifth item, range 0-3), (5) comprehension, reading, and writing (summed scores of the 6th-10th items, range 0-8), and figure copying (score of last item, range 0-1). Depressive symptoms were assessed with the Hong Kong version of the 15-item Geriatric Depression Scale at T1, T2, and T3. 16 Social support was assessed with the Lubben Social Network Scale on admission. 17 
Magnetic Resonance Imaging Analysis
All patients underwent brain MRI using a 1.5-Tesla scanner (Sonata; Siemens Medical, Erlangen, Germany) within 7 days of admission. Diffusion-weighted images, gradient echo, T1-and T2-weighted, and fluid attenuated inversion recovery sequences were included.
SVD markers and total burden. A qualified neurologist (Y.L.), who was blind to all clinical data and assessments reviewed all of the MRI images for SVD. The definitions of all SVD markers were based on the STRIVE consensus. 4 An ordinal scale devised and validated by Staals et al 18 was used to estimate the total SVD burden. Briefly, the presence of each of the 4 MRI markers for SVD (WMHs, lacunes, cerebral microbleeds, and enlarged perivascular spaces) was summed to form a total SVD score ranging from 0 to 4. White matter hyperintensities were assessed using the Fazekas scale, which ranges from 0 to 3.
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Extensive WMHs were defined if deep WMHs were scored as 2 or 3 or periventricular WMHs were scored as 3. One point was given for any extensive WMHs, cerebral microbleed, or lacunae. One point was awarded to perivascular spaces when more than 10 were located on one side of a single slice in the basal ganglia. 20 Infarcts. Another qualified neurologist (Y.K.C.), who was also blind to all clinical data and assessments assessed the number and volumes of acute infarcts. First, the contour of an acute infarct with restricted water diffusion identified on diffusionweighted imaging with b-values of 1000 was manually outlined. The total volume was then generated by multiplying the total area by the sum of the slice thickness and gap. 21 Inter-rater reliability. Thirty MRI scans were randomly selected for separate assessment by Y.L. and Y.K.C. The inter-rater k coefficients were 0.62 for WMHs lacunes, 0.76 for , 0.78 for cerebral microbleeds, 0.80 for enlarged perivascular spaces, and 0.66 for infarcts.
Statistical Analyses
Statistical analyses were conducted using SPSS software, version 24.0 (IBM) and Stata software, version 14.0 (Stata Corporation, College Station, Texas). Demographic and clinical characteristics are presented as means (standard deviations [SD]), medians (interquartile ranges or ranges), or proportions, as appropriate. The characteristics of patients who completed the follow-up and those who defaulted were compared with the w 2 , Fisher exact test, Mann-Whitney U test, or t test as appropriate. The XTREG module in STATA was used to estimate the association between SVD and cognitive function with linear mixed models. The dependent variable was MMSE scores, accounting for the random effect derived by repeated testing (3 visits: T1, T2, and T3) nested within each participants, while the independent variables were SVD and its interaction with time points. The longitudinal analysis was conducted by fitting linear mixed models using the XTREG module, because the models use all available follow-up data, handle missing data well, and consider that repeated measures on the same individual are correlated with each other. Generalized estimating equations (GEE) were constructed to ascertain the association between SVD and cognitive impairment (MMSE score 26). Variables significantly associated with MMSE scores in the univariate linear mixed models were conceived as covariates and thereby entered the multivariate models. Results were considered significant at P < .05 (2 sided).
Results
Characteristics of the Study Cohort
The final analyses included 451 participants ( Figure 1 ). Compared with the excluded patients (n ¼ 1248), the study participants had less severe stroke (NIHSS, 3 [1] [2] [3] [4] [5] versus 3 [1-6]; P < .001) (data not shown). Similar distributions in the demographic, clinical, and radiological characteristics were found between study participants and patients defaulted (n ¼ 122; Table 1 ).
The mean age of the sample was 66.0 (SD ¼ 10.3) and 44.1% were women. Over half of the patients had at least one vascular risk factor; about two-thirds had an acute infarct. Almost half (44.0%) had an SVD burden of mild severity or had no signs of any SVD lesion. About one-fifth presented with clinically significantly depressive symptoms, and their cognitive functions were relatively good with mean MMSE scores of 27.1 (SD ¼ 3.0), 27.1 (SD ¼ 3.2), and 26.9 (SD ¼ 3.6) at T1, T2, and T3, respectively (Table 1) .
Relationship Between SVD Burden and Cognitive Function at 15-Month Follow-Up
After adjustment for demographic variables, MMSE scores decreased by 0.36 units per SVD score (standard error [SE] ¼ 0.12, P ¼ .003; Model 1; Table 2 ). The MMSE scores decreased by 0.33 units per SVD score rise (SE ¼ 0.13, P ¼ .008) after further adjustment for vascular risks, stroke severity, characteristics of acute infarcts, and depressive symptoms (Model 2, Table 2 ). No interaction effect of time was found in the relationship between SVD scores and cognitive dysfunction. In the GEE models (Models 1 and 2; Table 3 ). In addition, SVD burden was significantly and negatively associated MMSE orientation to place and time Table 2 ). The GEE models produced similar findings: WMHs (OR ¼ 1.15; 95% CI ¼ 1.02-1.26) significantly associated with cognitive impairment 1 year after stroke (Model 4; Table 3 ). 
Other Predictors of Poststroke Cognitive Dysfunction
Age, female sex, education, depressive symptoms after stroke, stroke severity, and cortical infarcts were the independent predictors of cognitive dysfunction 1-year following stroke (Supplementary Table 1 ). The R 2 of the univariate linear mixed models with SVD burden, volume of acute infarcts, cortical infarcts, and old infarcts as predictors were 0.026, 0.013, 0.018, and 0.006, respectively (Supplementary Table 2 ).
Discussion
The main finding of this study was that greater SVD burden, representing the total brain damage associated with SVD, was associated with cognitive dysfunction measured by MMSE 1 year after stroke in a cohort of patients with mild-to-moderate acute ischemic stroke. Specifically, SVD burden was associated with poor performance in certain MMSE subscores including orientation to place and time, calculation, and word recall. Of the four SVD markers examined, WMHs showed the most robust association with poststroke cognitive dysfunction.
These findings support the work in this area that has linked SVD burden with cognitive dysfunction after stroke. The TABASCO study reported a negative relationship between total SVD score and cognitive performance 1 year after stroke or TIA in the unadjusted model, though this association disappeared after adjustment for demographic and imaging confounders. 11 Both the cross-sectional and longitudinal results from another cohort study in a hypertensive population also suggest that SVD burden predicts cognitive impairment. 8, 9 The recent findings from Shi et al also supported our data by confirming that a combination of SVD markers predicted both global cognitive performance and multiple cognitive areas (memory, attention, executive, and visuospatial functions) better than a single acute infarct or SVD marker at 3 to 6 months after ischemic stroke. 10 Similar observations were made in cross-sectional, population-based studies of older Abbreviations: CI, confidence interval; GEE, generalized estimating equations; MMSE, Mini-Mental State Examination; OR, odds ratio; SVD, small vessel disease; WMHs, white matter hyperintensities. a n ¼ 451. b Models 1 and 3 were adjusted for time points, age, sex, years of education, and social support.
c Models 2 and 4 were adjusted for age, sex, years of education, and social support, hypertension, smoking, the volume of acute infarcts, cortical acute infarcts, presence of old infarcts, and depressive symptoms.
adults, in which the concurrence of multiple SVD markers, compared with a single marker, was associated with poorer cognitive ability. 22, 23 Taken together, these findings suggest that SVD burden is a risk factor for poststroke cognitive dysfunction. Unlike TABASCO study with one-time assessment of cognitive functions, our study examined poststroke cognitive abilities 3 times over a 15-month follow-up, which enabled to delineate the impacts of SVD burden on changes of cognitive performances.
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Among the SVD markers in this study, WMHs were the strongest predictor of decrease in MMSE scores after stroke. The TABASCO study found that WMHs rather than SVD burden was significantly associated with poststroke cognitive decline. 11 Stroke patients with preexisting white matter lesions are more vulnerable to cognitive impairment regardless of the ischemic lesions. 24 White matter hyperintensity was also found to be a greater contributor to cognitive decline than other SVD markers in patients with hypertension. 9 Among the SVD markers, WMHs were the optimal indicator of the accumulated damaging effects of aging, vascular risk factors, ischemia, inflammation, and amyloid deposition. 25 Widespread WMHs might cause more diffusive damage to the brain's network than a single or several microbleeds and lacunae, resulting in impairments of several cognitive functions because white matter contains long projections and critical connecting tracts related to cognition. 25, 26 Furthermore, WMHs were associated with larger core infarct volumes 27 and an increased risk of hemorrhagic conversion after thrombolysis, 28 which, in turn, may delay cognitive recovery after stroke.
This study also revealed that SVD burden was related to poorer performance in some MMSE subscores including orientation to place and time, calculation, and word recall in patients with ischemic stroke. Consistently, previous research reported that disruption of white matter integrity caused by SVD contributed to deficits of working memory or delayed recall in patients with SVD. 29, 30 It remains controversy if SVD burden outweighs WMHs alone in predicting cognitive dysfunction after stroke. Two studies failed to support the advantage of SVD burden over WMHs. 11, 22 In contrast, SVD burden has been shown to outweigh a single marker in predicting poststroke disability, 6 recurrent stroke, 7 and depressive symptoms. 5 In a cohort study of older adults, the association between general cognitive ability and SVD burden remained significant even after WMHs were eliminated from the SVD score model. This finding suggested the necessity of combining SVD markers. 21 However, our study replicated the finding of the TABASCO study by showing that the effects of WMHs on cognitive status were larger than that of SVD burden. This finding was possibly related to the imperfect constructing method of SVD burden. This widely used SVD score lacks information about the locations and etiologies of SVD, and about the number of cerebral microbleeds and lacunes. Moreover, cerebral atrophy and cerebral microinfarcts, two other critical factors that contribute to the development of cognitive impairment, 29 are still not incorporated in the current SVD score. Hence, the association of SVD burden and cognitive changes after stroke may be underestimated in this study due to these shortcomings of the assessment method.
In addition, the present study revealed that SVD burden might outweigh size or location of infarcts in perpetuating cognitive dysfunction following stroke. Our results lent further support to the finding of the TABASCO study that ischemic lesions' volume did not contributed to global cognitive status, while the WMHs showed predominant effects in patients with mild-to-moderate ischemic stroke. 24 Xu et al demonstrated that WMHs rather than cortical infarcts were significant predictor of cognitive impairment in patients recruited from memory clinics. 31 One possible explanation was that the accumulating SVD lesions impaired cognitive resilience of stroke patients, thus predisposing cognitive impairment once after ischemic lesions occurred. 32 Several limitations of the study should be addressed. The major limitation is that the study predominantly included patients with mild-to-moderate stroke, and thus the results may not be applicable to patients with more severe stroke. Second, the stroke subtypes were not diagnosed. Third, participants' cognitive status was determined by the MMSE, which has limited sensitivity to detect milder cognitive impairment 33 and might lead to underestimation of the association between SVD burden and poststroke cognitive dysfunction. In addition, prestroke cognitive status was not systemically assessed, although patients who had dementia according to their medical records were excluded. Moreover, hippocampus, cortical atrophy, or amyloid pathologies were not examined. Future welldesigned studies are warranted to examine the interaction between cerebral small and large vessel diseases, and amyloid pathologies in affecting cognitive decline after stroke. Nonetheless, these limitations are offset, in part, by the strengths of the study, which included a relatively large sample size, a wellcharacterized stroke population, the use of standardized assessment instruments, and the 1-year longitudinal follow-up comprising 3 assessments. Finally, the 4-point scale used to estimate SVD burden in the current study lacked information about severity and locations of lacunes and cerebral microbleeds, which may lead to underestimate the total load of SVD. A more comprehensive assessment tool of SVD burden may be useful for future studies.
In conclusion, SVD burden is an alternative surrogate marker of cognitive dysfunction measured by the MMSE, at least in the first year after stroke, in patients with mild-to-moderate acute ischemic stroke. The SVD score seems to be suitable for screening stroke survivors at risk of cognitive dysfunction or dementia. SVD markers could be potential targets for treatment in clinical trials to decrease the risk of cognitive decline after stroke.
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